OurCrowd portfolio company MigVax Ltd., a startup developing an oral subunit vaccine against COVID-19, has announced promising results from preclinical tests that demonstrated the effectiveness of its MigVax-101 booster for previously vaccinated persons. According to a note distributed by the company, tests carried out on… Read More
Read more in: Offerings, Global | Tagged israel, migvax, ourcrowd
OurCrowd portfolio company, MigVax Corp., an Israeli company developing a vaccine for COVID-19, has selected Eyal Desheh as chairman of its board of directors. Desheh has previously served as an executive at Teva Pharmaceuticals, Check Point Software Technologies and currently is on the Board… Read More
Read more in: Global, Offerings | Tagged coronavirus, covid-19, eyal desheh, israel, migvax, ourcrowd
OurCrowd portfolio company Zebra Medical Vision, a deep-learning Medtech company, has announced its fifth FDA 510(k) clearance for its Vertebral Compression Fractures (VCF) product. The VCF product expands the company’s growing “AI1” (all-in-one) bundle of FDA cleared AI solutions. The company explains that nearly half… Read More
Read more in: Global, Investment Platforms and Marketplaces, Offerings | Tagged coronavirus, covid-19, israel, kyron, medtech, migvax, ourcrowd, zebra medical vision
OurCrowd, the world’s largest crowdfunding venture investment platform, has announced it would lead a $12 million funding round in MigVax Corporation – a startup that is developing a COVID-19 vaccine. MigVax is affiliated with the Migal Galilee Research Institute, is pioneering the effort to develop… Read More
Read more in: Global, Investment Platforms and Marketplaces, Offerings | Tagged coronavirus, covid-19, david zigdon, israel, jon medved, migal galilee research institute, migvax, morris laster, ourcrowd
© 2021 Crowded Media Group. All Rights Reserved.